Journal of Clinical Toxicology
Open Access
Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Recommended Journals
Relevant Topics
- Adverse Drug Reactions
- Aflatoxins
- Anvisa Drug Safety Regulations
- Applied Toxicology
- Aquatic Toxicology
- Biochemical Metabolism
- Biomedical Toxicology
- Cardiac Toxicity
- Chemical Toxicology
- Clinical Pharmacoepidemiological Trails
- Clinical Toxicology
- Computational Toxicology
- Cutaneous Toxicology
- Cytochrome 450 Drug Metabolism
- Cytotoxicity
- Detoxification
- Developmental Toxicology
- Drug Delivery
- Drug Interaction
- Drug Reactions
- Drug Safety Databases
- Drug Safety Information Maintenance
- Drug Safety Regulations
- Drug Toxicity
- Drug Toxicology
- Drug drug interaction
- Drug food interaction
- Drugs metabolised by CYP2D6
- Environmental Chemical Toxicology
- Environmental Contamination Toxicology
- Environmental Mutagenicity
- Environmental Toxicology
- Europeon Drug Safety Regulations
- Excitotoxicity
- Experimental Toxicology
- Expert Opinions on Drug Safety
- Genetic Toxicology
- Heavy Metal Toxicity
- Heavy Metal Toxins
- Hepatic Metabolism of Drugs
- Industrial Hygiene Toxicology
- Inhalation Toxicology
- Insect Toxins
- Insecticides Toxicology
- Liver Drug Metabolism
- Medication Errors
- Metal Toxicology
- Microbial Toxins
- Molecular Toxicology
- Mycotoxin
- Nano Toxicology
- Neuro Toxicology
- Occular Toxicology
- Occupational Toxicology
- Pediatric Toxicology
- Persistent Organic Pollutants
- Pesticidal Toxicology
- Pharmaceutical Toxicology
- Pharmacoepidemiological Studies
- Pharmacotherapy
- Phase I Drug Metabolism
- Phase II Drug Metabolism
- Poisonous Effects
- Pollution management
- Predictive Environmental Toxicology
- Regulatory updates of Environmental Toxicology
- Renal Toxicity
- Reproductive Toxicology
- Reviews on Drug Safety
- Sewage Pollution
- Skin Toxicology
- Tetanus Toxin
- Toxicity
- Toxicogenomics
- Toxicology Methods and Mechanisms
- Toxicology Reports
- Toxicology Testing
- Toxin
- UK Drug Safety Regulations
- US Drug Safety Regulations
- Veterinary Toxicology
| Liu Shu | ||
|
Shu Liu Postdoctoral Fellow Thoracic Oncology Laboratory University of California USA |
|
| Biography | ||
Shu Liu joined the Thoracic oncology lab in Oct., 2012 as a postdoctoral fellow. Her main research interest here is small molecule drug development. She works on several of exciting drug discovery projects using computational chemistry methods to rationally design, optimize properties of drug candidates and predict ADMET profiles. She also characterizes compounds to understand their activities both in vitro and in vivo. Liu has a Ph.D. in pharmaceutical sciences from College of Pharmacy, University of South Carolina in 2012. She received her Ph.D training from her advisor Dr. Campbell McInness in the drug design and synthesis lab. Liu\s dissertation is entitled design of non-ATP competitive and cell cycle specific CDK inhibitors targeting cyclin binding groove. She also has a B.S. in biological sciences from University of Science and Technology of China in 2005. Her college research work was about transdermal drug delivery. |
||
| Research Interest | ||
Small molecule drug development, Computational chemistry, Rational drug designing. |
||
Global Speakers in the subjectGlobal Experts in the subject | ||
